Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4522-4529

  Singleton, J Robinson ^a   Randolph, Ann E ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CLONING; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NEUROBLASTOMA; PREVENTION; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR GROWTH;

APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; NEOPLASM PROTEINS; NEUROBLASTOMA; NEURONS; PHENOTYPE; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS; SCHWANN CELLS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029738916     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Carlsen, N L. T Neuroblastoma epidemiology and pattern of regression. Problems in interpreting results of mass screening. Am J. Pediatr Hematol. Oncol., 14: 103-110, 1992.
2. Philip, T. Overview of current treatment of neuroblastoma. Am. J. Pediatr. Hematol. Oncol , 14: 97-102, 1992.
3. Biedler, J. L , Spengler, B. A., Tien-ding, C , and Ross, R. A. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Adv Neuroblastoma Res., 2: 265-276, 1988.
4. Martin, D M., and Feldman, E L. Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J. Cell. Physiol , 155 290-300, 1993.
5. Martin, D M., Singleton, J. R., Meghani, M. A., and Feldman, E. L. IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regul. Pept., 48, 225-232, 1993.
6. Leventhal, P. S., Randolph, A. E. Vesbit, T. E., Schenone, A., Windebank, A. J., and Feldman, E L Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp. Cell Res., 221: 179-186, 1995.
7. D'Amico, A. V , and McKenna, W. G. Apoptosis and a re-investigation of the biologic basis for cancer therapy Radiother. Oncol., 33: 3-10, 1994.
8. Schulte-Hermann, R., Grasl-Kraupp, B., and Bursch, W Tumor development and apoptosis. Int. Arch. Allergy Immunol., 105: 363-367, 1994.
9. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777-779, 1993
10. Kaleko, M., Rutter, W J., and Miller, A. D. Overexpression of the human insulin like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10, 464-473, 1990.
11. Sell, C , Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
12. Baserga, R The insulin-like growth factor I receptor a key to tumor growth? Cancer Res , 55: 249-252, 1995.
13. Baserga, R Oncogenes and the strategy of growth factors. Cell, 79: 927-930, 1994.
14. Yee, D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res Treat , 32, 85-95, 1994.
15. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994
16. Sell, C , Rubini, M., Rubin, R , Liu, J-P , Efstratiadis, A , and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl. Acad Sci. USA, 90, 11217-11221, 1993.
17. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest., 94: 1235-1242, 1994.
18. LeRoith, D , Baserga, R., Helman, L., and Roberts, C. T., Jr. Insulin-like growth factors and cancer. Ann. Intern. Med., 122, 54-59, 1995
19. Biedler, J L , Roffler-Tarlov, S., Schachner, M., and Freedman, L. S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res., 38: 3751-3757, 1978.
20. Cullen, K J , Lippman, M. E., Chow, D., Hill, S., Rosen, N., and Zwiebel, J. A. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol., 6, 91-100, 1992
21. Felgner, P. L., Gadek, T. R., Holm, M , Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., and Danielsen, M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA, 84: 7413-7417, 1987.
22. Feldman, E L., and Randolph, A. E Mannose 6-phosphate potentiates insulin-like growth factor II effects in cultured human neuroblastoma cells. Brain Res., 562: 111-116, 1991.
23. Hansen, M., Nielsen, S., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J. Immunol. Methods, 119: 203-210, 1989.
24. Meghani, M A , Martin, D. M , Singleton, J. R., and Feldman, E. L. Effects of serum and insulin-like growth factors on human neuroblastoma cell growth. Regul. Pept., 48: 217-224, 1993.
25. Darzynkiewicz, Z , Bruno, S , DelBino, G., Gorczyca, W , Hotz, M. A , Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
26. Martin, D. M , and Feldman, E. L Reversibility of serum removal effects on IGF-II mRNA in human neuroblastoma cells. In: M. K. Raizada and D. LeRoith (eds.), The Role of Insulin-Like Growth Factors in the Nervous System, pp. 259-261 New York: The New York Academy of Sciences, 1993
27. Matthews, C C., Dieckmann, C., and Feldman, E L IGF-I rescues neurons from hyperosmotic-induced programmed cell death. Endocr Soc Abstr. OR28-3: 82, 1995.
28. Rivera, G. K., Pui, C-H., Santana, V. M., Pratt, C B , and Crist, W. M. Epipodophyllotoxins in the treatment of childhood cancer. Cancer Chemother. Pharmacol. 34 (Suppl): S89-S95, 1994.
29. Majno, G., and Joris, I Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol., 146: 3-15, 1995.
30. Martin, S J., and Green, D. R Apoptosis and cancer, the failure of controls on cell death and cell survival. Crit. Rev. Oncol-Hematol , 18: 137-153, 1995.
31. Zackenfels, K., Oppenheim, R. W., and Rohrer, H. Evidence for an important role of IGF-I and IGF-II for the early development of chick sympathetic neurons. Neuron, 14: 731-741, 1995.
32. Beck, K. D., Powell-Braxton, L., Widmer, H-R., Valverde, J., and Hefti, F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons Neuron, 14: 717-730, 1995.
33. Norstedt, G , Levinovitz, A., Moller, C , Eriksson, L. C , and Andersson, G. Expression of insulin-like growth factor I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis (Lond.), 9: 209-213, 1988.
34. Unterman, T G., Glick, R. P , Waites, G T , and Bell, S. C. Production of insulin-like growth factor-binding proteins by human central nervous system tumors Cancer Res., 51: 3030-3036, 1991.
35. Glick, R. P , Unterman, T. G , Van der Woude, M , and Zollner Blaydes, L. Insulin and insulin-like growth factors in central nervous system tumors. Part V: production of insulin-like growth factors I and II in vitro. J. Neurosurg., 77: 445-450, 1992.
36. El-Badry, O M. Insulin-like growth factor II gene expression in human neuroblastoma. Prog. Clin Biol. Res , 366: 249-256, 1991.
37. Sullivan, K. A , Castle, V. P., Hanash, S. M , and Feldman, E. L. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am. J. Pathol., 147, 1790-1798, 1995.
38. Sell, C , Dumenil, G., Deveaud, C., Miura, M , Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts Mol Cell Biol. 14: 3604-3612, 1994.
39. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S , and Baserga, R Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res , 54: 4848-4850, 1994.
40. Matthews, C. C., Bryant, J., and Feldman, E. L IGF-I rescues neurons from hyperosmotic shock. Soc. Neurosci. Abstr , 20: 231, 1994.
41. Trojan, J , Blossey, B K., Johnson, T. R., Rudin, S. D , Tykocinski, M , and Ilan, J Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc. Natl. Acad Sci. USA, 89: 4874-4878, 1992.
42. Resnicoff, M., Sell, C , Rubini, M , Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (1GF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54: 2218-2222, 1994.
43. Resnicoff, M , Abraham, D., Rubin, R., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Proc. Am Assoc Cancer Res., 36: 6, 1995
44. Garcia, I., Martinou, I., Tsujimoto, Y , and Martinou, J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science (Washington DC), 258: 302-304, 1992
45. Wyllie, A. H , Kerr, J. F R., and Currie, A. R Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980
46. Raff, M. C., Barres, B. A., Burne, J F , Coles, H S., Ishizaki, Y , and Jacobson, M D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science (Washington DC), 262: 695-700, 1994.
47. Miyashita, T., and Reed, J. C Tumor suppressor p53 is a direct transcriptional activator of the human box gene Cell, 80: 293-299, 1995
48. Sato, T., Hanada, M , Aime-Sempe, C., Zha, H., Bodrug, S., Kobayashi, H , Fong, L., Iwama, N., and Reed, J. C. Investigations of Bcl-2, Bax, Bcl-X, and Mcl-1 protein interactions and function using yeast. Proc. Am. Assoc. Cancer Res , 36: 9, 1995.
49. Farrow, S. N., White, J. H. M., Martinou, I , Raven, T., Pun, K-T , Grinham, C. J., Martinou, J-C., and Brown, R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (Lond.), 374: 731-733, 1995.
50. 2+ fluxes Proc Natl. Acad. Sci. USA, 91: 6569-6573, 1994.
51. Castle, V P., Heidelberger, K. P , Bromberg, J , Ou, X., Dole, M., and Nuñez, G Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol., 143: 1543-1550, 1993.
52. Krajewski, S., Chatten, J., Hanada, M., and Reed, J. C. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas: comparisons with tumor cell differentiation and N-Myc protein. Lab Invest., 71: 42-54, 1995.
53. Martinou, J-C , Dubois-Dauphin, M , Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D , Catsicas, S., Pietra, C., and Huarte, J Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron, 13: 1017-1030, 1994.
54. Dole, M., Nunez, G., Merchant, A. K., Maybaum, J., Rode, C. K , Bloch, C. A., and Castle, V. P Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res., 54: 3253-3259, 1994
55. Mills, E. M., Vanden Heuvel, J. P., and Isom, G. E. Differential sensitivity to cyanide cytotoxicity during PC12 cell differentiation: correlation with altered BCL-2 expression Soc. Neurosci Abstr 21: 751, 1995.
56. Ravera, F., Miglietta, L., Pirani, P., Ferrini, S., and Favoni, R. E. Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events. Eur. J. Cancer, 29A: 225-230, 1993